MktsMarkets

Korro Bio, Inc.
NASDAQ: KRROKey statistics
KRRO News
Stories mentioning KRRO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 1,292 | 1,090 | 1,460 | 2,550 | 2,271 | 0.00 | 0.00 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 12,951 | 10,985 | 13,820 | 21,031 | 19,739 | 16,962 | 15,964 | 17,138 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 20,436 | 51,688 | 20,327 | 28,662 | 27,570 | 25,311 | 23,292 | 24,125 |
| Operating Income (Loss) | (20,436) | (50,396) | (19,237) | (27,202) | (25,020) | (23,040) | (23,292) | (24,125) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 906.00 | 990.00 | 1,176 | 1,433 | 1,633 | 1,944 | 2,284 | 2,329 |
| Pretax Income | (19,530) | (49,406) | (18,061) | (25,769) | (23,387) | (21,096) | (21,008) | (21,796) |
| Tax Provision | 95.00 | 636.00 | 0.00 | 1.00 | 0.00 | 103.00 | (9.00) | 30.00 |
| Net Income (Loss) | (19,625) | (50,042) | (18,061) | (25,770) | (23,387) | (21,199) | (20,999) | (21,826) |
| Earnings Per Share (Basic) | (1.69) | (5.33) | (1.92) | (2.74) | (2.49) | (2.38) | (2.26) | (2.43) |
| Earnings Per Share (Diluted) | (1.69) | (5.33) | (1.92) | (2.74) | (2.49) | (2.38) | (2.26) | (2.43) |
| Weighted Average Shares Outstanding (Basic) | 11,599 | 9,395 | 9,392 | 9,391 | 9,384 | 8,921 | 9,303 | 8,987 |
| Weighted Average Shares Outstanding (Diluted) | 11,599 | 9,395 | 9,392 | 9,391 | 9,384 | 8,921 | 9,303 | 8,987 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About KRRO
Korro Bio, Inc. (NASDAQ: KRRO) is a stock listed on the Nasdaq Stock Market under the ticker symbol KRRO. It last traded at $12.44 (Nov 18, 2026, 4:00 PM ET), up 1.0% on the day. That gives Korro Bio a market capitalisation of $173.9M.
Over the past 52 weeks KRRO has traded between $5.20 and $17.35.
Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $19.6M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $0 | -$19.6M | — |
| Dec 31, 2025 | $1.3M | -$50.0M | -3873.2% |
| Sep 30, 2025 | $1.1M | -$18.1M | -1657.0% |
| Jun 30, 2025 | $1.5M | -$25.8M | -1765.1% |
From Korro Bio’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…